As Medicines Co (MDCO) Valuation Declined, Westfield Capital Management Company LP Increased by $9.06 Million Its Stake

October 13, 2018 - By whatsonthorold

The Medicines Company (NASDAQ:MDCO) LogoInvestors sentiment increased to 1.09 in Q2 2018. Its up 0.07, from 1.02 in 2018Q1. It is positive, as 24 investors sold MDCO shares while 51 reduced holdings. 27 funds opened positions while 55 raised stakes. 89.10 million shares or 2.14% less from 91.05 million shares in 2018Q1 were reported. Ameritas Inv Partners has invested 0.01% of its portfolio in The Medicines Company (NASDAQ:MDCO). Two Sigma Securities Limited Liability Com holds 0% or 25,542 shares in its portfolio. Numerixs Invest Technologies owns 6,600 shares. Pinnacle Associates Ltd accumulated 945,612 shares. Bain Equity Mgmt Lc reported 52,807 shares. State Board Of Administration Of Florida Retirement invested in 0% or 43,419 shares. Piedmont Invest Ltd stated it has 15,165 shares or 0.03% of all its holdings. Trexquant Inv Limited Partnership reported 27,414 shares or 0.07% of all its holdings. Sarissa Lp owns 14.14% invested in The Medicines Company (NASDAQ:MDCO) for 1.92 million shares. Comerica Natl Bank holds 0.02% or 68,769 shares in its portfolio. 2.03 million were accumulated by State Street Corporation. Invesco Ltd owns 528,773 shares. Opus Point Partners Management Ltd Liability Company holds 0.56% or 7,000 shares in its portfolio. Prudential Inc holds 109,742 shares. Three Bays Capital Ltd Partnership stated it has 1.36M shares.

Since May 25, 2018, it had 0 buys, and 3 selling transactions for $4.01 million activity. Shares for $241,500 were sold by Spigelman Melvin K.

Westfield Capital Management Company Lp increased its stake in Medicines Co (MDCO) by 8.3% based on its latest 2018Q2 regulatory filing with the SEC. Westfield Capital Management Company Lp bought 251,572 shares as the company’s stock declined 6.59% while stock markets rallied. The institutional investor held 3.28 million shares of the major pharmaceuticals company at the end of 2018Q2, valued at $120.42 million, up from 3.03M at the end of the previous reported quarter. Westfield Capital Management Company Lp who had been investing in Medicines Co for a number of months, seems to be bullish on the $1.93B market cap company. The stock decreased 0.08% or $0.02 during the last trading session, reaching $26.23. About 770,362 shares traded. The Medicines Company (NASDAQ:MDCO) has declined 1.05% since October 13, 2017 and is downtrending. It has underperformed by 16.67% the S&P500.

Westfield Capital Management Company Lp, which manages about $17.38 billion and $13.40B US Long portfolio, decreased its stake in E Trade Financial Corp (NASDAQ:ETFC) by 187,710 shares to 732,725 shares, valued at $44.81M in 2018Q2, according to the filing. It also reduced its holding in Costar Group Inc (NASDAQ:CSGP) by 105,127 shares in the quarter, leaving it with 157,617 shares, and cut its stake in Wns Holdings Ltd (NYSE:WNS).

More news for The Medicines Company (NASDAQ:MDCO) were recently published by: Seekingalpha.com, which released: “Most Heavily Shorted Stocks Tank In September” on September 28, 2018. Seekingalpha.com‘s article titled: “The Medicines Company’s late-stage inclisiran studies to continue as planned” and published on October 01, 2018 is yet another important article.

The Medicines Company (NASDAQ:MDCO) Ratings Coverage

Among 2 analysts covering Medicines Co (NASDAQ:MDCO), 2 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Medicines Co had 2 analyst reports since June 6, 2018 according to SRatingsIntel. The rating was maintained by Citigroup with “Buy” on Monday, August 20. The firm earned “Buy” rating on Wednesday, June 6 by FBR Capital.

The Medicines Company (NASDAQ:MDCO) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

>